Thanks to our numerous co-operations with companies and partner institutions, you receive access to innovative medical diagnostic and treatment forms.
Cardiovascular diseases, obesity, food intolerances and certain autoimmune disorders are influenced both by genetic factors as well as by diet and lifestyle. Genetic testing gives you valuable insights and tips on prevention.
The body’s reaction to specific foods depends on your individual genetic predisposition. If you have certain genetic variations, some dietary habits may increase the risk of developing specific illnesses. It is therefore vital to know about your genetic predisposition so you can make the right adjustments to your diet.
Further genetic tests can be found in the section «Costs covered for further genetic and laboratory analyses with PRIMEO supplementary insurance».
Do oral contraceptives increase the risk of thrombosis? Is there a risk of my unborn child suffering a genetic disorder? How high is the risk of cancer in my family? Take a test to see if you or your family are affected.
The Pill Protect genetic test determines your risk of suffering from venous thrombosis as a result of taking the contraceptive pill. The test also considers other risk factors in its analysis.
From as early as the ninth week of pregnancy, non-invasive tests, i.e. tests that do not require devices or catheters to be inserted into the body, can determine with a high level of certainty whether an unborn child has a genetic disorder such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) or trisomy 13 (Patau syndrome).
As of mid-July 2015, this examination (trisomy 21, 18 and 13) has been covered by basic insurance, provided the requirements of the Health Care Benefits Ordinance (KLV) are met. If these requirements are not met, PRIMEO supplementary insurance covers the costs.
5% to 10% of all cancers are hereditary. Since the mutations can be inherited, cancer cases often occur in clusters in the families affected. A genetic test can offer clarity and confirm the presence of mutations for the most common hereditary cancers.
Further genetic tests can be found in the section «Costs covered for further genetic and laboratory analyses with PRIMEO supplementary insurance».
A diagnosis of cancer causes uncertainty and worry for those affected. It raises many questions. An appropriate test can offer some clarity and help you choose the right treatment.
Prolaris is a gene expression test that can help to predict how prostate cancer may progress. The test is carried out on existing tumour tissue (biopsy) and accurately measures the activity of specific genes that directly influence tumour growth.
Conventional tests exclusively recognise hereditary changes detected in the blood. The Tumor BRACAnalysis, meanwhile, also reveals mutations that only occur in the tumour.
Melanoma is a form of skin cancer that can be fatal if not treated early. For this reason, it's important to distinguish between an innocuous mole or birthmark and a malignant melanoma. However, 10% to 15% of tests performed do not provide conclusive results. The myPath Melanoma test can offer greater clarity in these cases.
Further genetic tests can be found in the section «Costs covered for further genetic and laboratory analyses with PRIMEO supplementary insurance».
Medications can trigger unwanted side effects and in some cases they may even be ineffective. Different medications can also interact with one another if you have to take several at the same time.
The effect of any medication is influenced by metabolic processes: how the body converts and eliminates substances. The Cypass genetic test assesses these metabolic processes as well as 16 genes and 97 clinically significant genetic variants that are involved in the breaking down and tolerability of medications in the body.
The Cypass Extended genetic test is more comprehensive than the Cypass test. It analyses 25 genes in addition to 127 genetic variants that are involved in the breaking down and tolerability of medications.
Statins are the most commonly prescribed medication in Switzerland. They help reduce blood lipid levels, in particular “bad” cholesterol (30–50%), and play a role in reducing the risk of cardiovascular disease. However, the effectiveness of statins is impacted by certain genetic variants that are part of the patient's DNA.
Further genetic tests can be found in the section «Costs covered for further genetic and laboratory analyses with PRIMEO supplementary insurance».
If you have taken out PRIMEO supplementary insurance, Helsana will cover 90% of the costs up to a total of CHF 5,000 per calendar year for innovative diagnostic and treatment forms. Helsana will be invoiced directly for your test.
Patients with PRIMEO supplementary insurance receive exclusive paid access to other genetic tests:
Contact us on 0844 80 81 82 (Monday to Friday, from 8 a.m. to 12 p.m. and from 1 p.m. to 5 p.m.). We will review your request and notify you of the costs covered.
Genetic factors play a key role in some diseases. The enormous progress that has been made in medical genetics research is a key reason why today’s healthcare has improved.
With PRIMEO supplementary insurance, you benefit from direct access to leading experts in the field of medical genetics in Switzerland:
Do you have semi-private or private insurance? Then you can also benefit from the expert second opinion service.
Contact us on 058 340 13 84 (Monday to Friday, from 8 a.m. to 12 p.m. and from 1 p.m. to 5 p.m.). We will then contact a genetic expert.
Please note: consultations are offered in English and German.
Healthcare is constantly improving thanks to technological progress and digitisation. This enables us to develop even better and more accurate examination methods. Patients with PRIMEO supplementary insurance receive exclusive access to the following innovative examinations:
Contact us on 0844 80 81 82 (Monday to Friday, from 8 a.m. to 12 p.m. and from 1 p.m. to 5 p.m.). We will review your request and notify you of the costs covered.
You can perform a self-test from a pharmacy at home in order to obtain rapid, reliable results. Patients with PRIMEO supplementary insurance receive exclusive paid access to the following innovative quick tests:
Contact us on 0844 80 81 82 (Monday to Friday, from 8 a.m. to 12 p.m. and from 1 p.m. to 5 p.m.). We will review your request and notify you of the costs covered.
Medical technology products or medical aids are used to detect and treat illnesses. Patients with PRIMEO supplementary insurance receive exclusive paid access to the following medical products:
Contact us on 0844 80 81 82 (Monday to Friday, from 8 a.m. to 12 p.m. and from 1 p.m. to 5 p.m.). We will review your request and notify you of the costs covered.
These laboratory tests are not covered by basic insurance. For policyholders without PRIMEO supplementary insurance, Helsana has agreed the following special conditions for the tests listed above:
Helsana Group policyholders benefit from generous discounts on other medical innovations:
If you are interested in an innovative treatment form, please consult your doctor. Most tests are only carried out if prescribed by a doctor. The partner firms make the results directly available to the doctor.
We're here to help.